[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366812-105":59,"doc-detail-366812-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","translation-element-eif4a1-is-a-potential-divergent-immune-biomarker-between-colon-cancer-and-rectal-cancer","Translation element EIF4A1 is a potential divergent immune biomarker between colon cancer and rectal cancer","","Study investigates EIF4A1 as a subtype-specific molecular target linking colorectal cancer incidence to personalized immunotherapy needs. EIF4A1 roles are assessed through quantitative real-time PCR for expression and immunohistochemistry for protein localization. Multi-dimensional database analyses characterize EIF4A1 functions and heterogeneity in colon versus rectal cancer. Findings show EIF4A1 is upregulated in both cancers, correlating with poor survival, and producing divergent immune infiltration patterns. Strong associations include NET networks and neutrophil infiltration broadly, but CD8+ T cell positivity in colon contrasts with CD4+ T cell negativity in rectal, with stronger checkpoint molecule correlations in colon.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/translation-element-eif4a1-is-a-potential-divergent-immune-biomarker-between-colon-cancer-and-rectal-cancer/366812/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/translation-element-eif4a1-is-a-potential-divergent-immune-biomarker-between-colon-cancer-and-rectal-cancer/366812.png","ImageObject",300,407,{"name":92,"@type":93},"kopisore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study on EIF4A1 in colon and rectal cancer?","Question",{"text":112,"@type":113},"To investigate the role and therapeutic potential of EIF4A1 for colon and rectal cancers, focusing on subtype-specific molecular targets for immunotherapy guidance.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were EIF4A1 expression and protein levels measured?",{"text":117,"@type":113},"EIF4A1 expression was measured using quantitative real-time PCR (qRT-PCR), and protein expression was evaluated using immunohistochemistry (IHC).",{"name":119,"@type":110,"acceptedAnswer":120},"What immune-related differences did EIF4A1 show between colon and rectal cancers?",{"text":121,"@type":113},"EIF4A1 correlated positively with neutrophil infiltration in both subtypes and linked colon cancer to CD8+ T cells, while rectal cancer showed a negative correlation with CD4+ T cells; checkpoint molecule correlations were stronger in colon than in rectal cancer.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366812,1790497569,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090880963,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Translation element EIF4A1 is a potential divergent immune biomarker between colon cancer and rectal cancer  \nInternational Journal of Immunopathology and Pharmacology Volume 39: 1–26  \n© The Author(s) 2025  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/03946320251379175](DOI: 10.1177/03946320251379175)[ ](DOI: 10.1177/03946320251379175)[journals.sagepub.com/home/iji](journals.sagepub.com/home/iji)  \nZhenpeng Zhu 1*, Peng Wang2*, Chenyang Hou 1*, Jiajia Xiao 1, Fengxu Yan 1, Shan Liu3, Xiran Wang4, Xuejun Zhi5, Jun Xue6 Dandan Xu7, Fei Guo8, and Weizheng Liang7,  \nAbstract  \nObjective: Given the global high incidence of colorectal cancer (CRC) and the need for subtype-specific molecular targets, this study aims to investigate the role and therapeutic potential of EIF4A1 in colon and rectal cancers. Introduction: The potential of Eukaryotic translation initiation factor 4A1(EIF4A1) to guide prognosis and inform immunotherapeutic strategies in colon and rectal cancers warrants further investigation.  \nMethods: EIF4A1 expression levels were measured by quantitative real-time PCR (qRT-PCR), and EIF4A1 protein expression was evaluated via immunohistochemistry (IHC). Additionally, multi-dimensional database analyses were performed to characterize the biological functions of EIF4A1 and explore its heterogeneity in CRC.  \nResults: EIF4A1 expression was upregulated in both colon and rectal cancers, with significant associations with poor survival outcomes. Functional enrichment analyses indicated that EIF4A1 was predominantly associated with theneutrophil extracellular trap (NET) network in colon cancer. Strong positive correlations between EIF4A1 expression and neutrophil infiltration were observed in both cancer subtypes. Notably, EIF4A1 exhibited divergent immune infiltration patterns: a strong positive correlation with CD8 + T cells in colon cancer, versus a negative correlation with CD4 + T cells in rectal cancer. EIF4A1 also showed strong positive correlations with immune checkpoint molecules (PD-1, PD-L1, CTLA4, and LAG-3) in colon cancer, whereas these correlations were weaker in rectal cancer.  \n1 Hebei North University, Zhangjiakou City, Hebei Province, China. 2Graduate School of Hebei Medical University, Shijiazhuang City, Hebei Province, China.  \n3Institute of Bio-Architecture and Bio-Interactions (IBABI), Shenzhen Medical Academy of Research and Translation (SMART), Shenzhen, China.  \n4Department of Bioinformatics, School of Health Care, Changchun Vocational College of Health, Changchun City, Jilin Province, China. 5Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei Province, China.  \n6Hebei Key Laboratory of Systems Biology and Gene Regulation, Department of Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou City, Hebei Province, China.  \n7Hebei Key Laboratory of Systems Biology and Gene Regulation, Central Laboratory, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei Province, China.  \n8Hebei Key Laboratory of Systems Biology and Gene Regulation, Department of Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou City, Hebei Province, China.  \n*Zhenpeng Zhu, Peng Wang and Chenyang Hou contributed equally to this work.  \nCorresponding authors:  \nWeizheng Liang, Hebei Key Laboratory of Systems Biology and Gene Regulation, Central Laboratory, The First Affiliated Hospital of Hebei North University, 12 Changqing Road, Zhangjiakou, Hebei 075000, China.  \nEmail: [jmbb1203@126.com](jmbb1203@126.com)  \nFei Guo, Hebei Key Laboratory of Systems Biology and Gene Regulation, Department of Surgery, The First Affiliated Hospital of Hebei North University, Zhangjiakou, Hebei 075000, China.  \nEmail: [longer8020010@163.com](longer8020010@163.com)  \nDandan Xu, Hebei Key Laboratory of Sys","cbCaikqXV2LeWUqe","https://ap.wps.com/l/cbCaikqXV2LeWUqe","pdf",8882782,26,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main objective of the study on EIF4A1 in colon and rectal cancer?\",\"answer\":\"To investigate the role and therapeutic potential of EIF4A1 for colon and rectal cancers, focusing on subtype-specific molecular targets for immunotherapy guidance.\"},{\"question\":\"How were EIF4A1 expression and protein levels measured?\",\"answer\":\"EIF4A1 expression was measured using quantitative real-time PCR (qRT-PCR), and protein expression was evaluated using immunohistochemistry (IHC).\"},{\"question\":\"What immune-related differences did EIF4A1 show between colon and rectal cancers?\",\"answer\":\"EIF4A1 correlated positively with neutrophil infiltration in both subtypes and linked colon cancer to CD8+ T cells, while rectal cancer showed a negative correlation with CD4+ T cells; checkpoint molecule correlations were stronger in colon than in rectal cancer.\"}]","Translation element EIF4A1 is a potential divergent immune biomarker between colon cancer and rectal cancer | PDF",1790167673,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/16cfde293b848ad3a22ecf902908e330.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c1580dd26a0742afa1bd871aa91a4307.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c28df51c299de2176ec0f190547892e5.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5bb5569f46bdd828725029d4c07695fb.webp",980,1306]